CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome

被引：73

作者：

Kulkarni, Smita ^{[1
,2
,3
]}

Lied, Alexandra ^{[2
,3
]}

Kulkarni, Viraj ^{[2
,3
]}

Rucevic, Marijana ^{[2
,3
,4
]}

Martin, Maureen P. ^{[5
]}

Walker-Sperling, Victoria ^{[6
]}

Anderson, Stephen K. ^{[5
]}

Ewy, Rodger ^{[1
]}

Singh, Sukhvinder ^{[1
]}

Nguyen, Hoang ^{[1
]}

McLaren, Paul J. ^{[7
,8
]}

Viard, Mathias ^{[5
]}

Naranbhai, Vivek ^{[2
,3
]}

Zou, Chengcheng ^{[9
]}

Lin, Zhansong ^{[9
]}

Gatanaga, Hiroyuki ^{[9
,10
]}

Oka, Shinichi ^{[9
,10
]}

Takiguchi, Masafumi ^{[9
]}

Thio, Chloe L. ^{[11
]}

Margolick, Joseph ^{[12
]}

Kirk, Gregory D. ^{[13
]}

Goedert, James J. ^{[14
]}

Hoots, W. Keith ^{[15
]}

Deeks, Steven G. ^{[16
]}

Haas, David W. ^{[17
]}

Michael, Nelson ^{[18
]}

Walker, Bruce ^{[2
,3
,19
,20
]}

Le Gall, Sylvie ^{[2
,3
]}

Chowdhury, Fatema Z. ^{[2
,3
]}

Yu, Xu G. ^{[2
,3
]}

Carrington, Mary ^{[2
,3
,5
]}

机构：

[1] Texas Biomed Res Inst, San Antonio, TX 78227 USA

[2] MIT, Massachusetts Gen Hosp, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA

[3] Harvard Univ, Cambridge, MA 02138 USA

[4] Olink Prote, Watertown, MA USA

[5] Frederick Natl Lab Canc Res, Basic Sci Program, Frederick, MD 21701 USA

[6] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21701 USA

[7] Publ Hlth Agcy Canada, JC Wilt Infect Dis Res Ctr, Winnipeg, MB, Canada

[8] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada

[9] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan

[10] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan

[11] Johns Hopkins Univ, Dept Med, Baltimore, MD USA

[12] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA

[13] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA

[14] NCI, Epidemiol & Biostat Program, Div Canc Epidemiol & Genet, Rockville, MD USA

[15] NHLBI, Div Blood Dis & Resources, NIH, Bldg 10, Bethesda, MD 20892 USA

[16] San Francisco Gen Hosp, Med Ctr, San Francisco, CA 94110 USA

[17] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA

[18] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA

[19] Howard Hughes Med Inst, Chevy Chase, MD USA

[20] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA

来源：

NATURE IMMUNOLOGY | 2019年 / 20卷 / 07期

关键词：

LONG NONCODING RNAS; HOST GENETIC-VARIATION; MESSENGER-RNA; VIRUS REPLICATION; EXPRESSION; INFECTION; PROGRESSION; CELLS; HEPATITIS; DENSITY;

D O I：

10.1038/s41590-019-0406-1

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Multiple genome-wide studies have identified associations between outcome of human immunodeficiency virus (HIV) infection and polymorphisms in and around the gene encoding the HIV co-receptor CCR5, but the functional basis for the strongest of these associations, rs1015164A/G, is unknown. We found that rs1015164 marks variation in an activating transcription factor 1 binding site that controls expression of the antisense long noncoding RNA (lncRNA) CCR5AS. Knockdown or enhancement of CCR5AS expression resulted in a corresponding change in CCR5 expression on CD4(+) Tcells. CCR5AS interfered with interactions between the RNA-binding protein Raly and the CCR5 3' untranslated region, protecting CCR5 messenger RNA from Raly-mediated degradation. Reduction in CCR5 expression through inhibition of CCR5AS diminished infection of CD4(+) Tcells with CCR5-tropic HIV in vitro. These data represent a rare determination of the functional importance of a genome-wide disease association where expression of a lncRNA affects HIV infection and disease progression.

引用

页码：824 / +

页数：13

共 50 条

[21] Blocking CCR5
Chen I.
Nature Structural & Molecular Biology, 2013, 20 (10) : 1145 - 1145
[22] CCR5 and CCR5Δ32 in bacterial and parasitic infections: Thinking chemokine receptors outside the HIV box
Ellwanger, Joel Henrique
Kaminski, Valeria de Lima
Rodrigues, Andressa Goncalves
Kulmann-Leal, Bruna
Chies, Jose Artur Bogo
INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2020, 47 (03) : 261 - 285
[23] CCR5 gene editing - Revisiting pros and cons of CCR5 absence
Ellwanger, Joel Henrique
Kaminski, Valeria de Lima
Bogo Chies, Jose Artur
INFECTION GENETICS AND EVOLUTION, 2019, 68 : 218 - 220
[24] Effects of CC chemokine receptor 5 (CCR5) inhibitors on the dynamics of CCR5 and CC-chemokine-CCR5 interactions
Nakata, Hirotomo
Kruhlak, Michael
Kamata, Wakako
Ogata-Aoki, Hiromi
Li, Jianfeng
Maeda, Kenji
Ghosh, Arun K.
Mitsuya, Hiroaki
ANTIVIRAL THERAPY, 2010, 15 (03) : 321 - 331
[25] The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression
Nelson L. Michael
Leslie G. Louie
Amy L. Rohrbaugh
Kathleen A. Schultz
Debora E. Dayhoff
Carol E. Wang
Haynes W. Sheppard
Nature Medicine, 1997, 3 : 1160 - 1162
[26] Multiple CCR5 Conformations on the Cell Surface Are Used Differentially by Human Immunodeficiency Viruses Resistant or Sensitive to CCR5 Inhibitors
Berro, Reem
Klasse, Per Johan
Lascano, Danny
Flegler, Ayanna
Nagashima, Kirsten A.
Sanders, Rogier W.
Sakmar, Thomas P.
Hope, Thomas J.
Moore, John P.
JOURNAL OF VIROLOGY, 2011, 85 (16) : 8227 - 8240
[27] CCR2, CCR5, and CXCL12 variation and HIV/AIDS in Papua New Guinea
Mehlotra, Rajeev K.
Hall, Noemi B.
Bruse, Shannon E.
John, Bangan
Zikursh, Melinda J. Blood
Stein, Catherine M.
Siba, Peter M.
Zimmerman, Peter A.
INFECTION GENETICS AND EVOLUTION, 2015, 36 : 165 - 173
[28] CCR5, vertical transmission of HIV-1, and disease progression
Bailey, AJ
Newell, ML
De Rossi, A
Giaquinto, C
Iasci, A
Ravizza, M
Garcia-Rodriguez, MC
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1999, 20 (02): : 211 - 212
[29] CCR5 genotypes and progression to HIV disease in perinatally infected children
Araujo de Angelis, Daniela Souza
Freire, Wilton Santos
Pannuti, Claudio Sergio
de Menezes Succi, Regina Cella
Machado, Daisy Maria
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (02): : 196 - 198
[30] Polymorphism of CCR5 affecting HIV disease progression in the Japanese population
Kageyama, S
Mimaya, JI
Yamada, K
Kurimura, T
Shiraki, K
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (11) : 991 - 995

← 1 2 3 4 5 →